CSP-9222 is a novel small molecule designed to induce apoptosis for the treatment of cancer.

Via activation of caspases 3/7 and inducer of Fas Ligand (Fasl), CSP-9222 has potential broad application in a variety of cancers including breast, colon, lung, ovarian, pancreatic, prostate and melanoma

In preclinical studies, CSP-9222 inhibited cell growth and demonstrated a delay in disease progression in breast, colon, and drug-resistant colon cancer (xenograft models in mice).